Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain
Appendix B-8: Opioid Conversion and Brand Availability in Canada
- Oral Opioid Analgesic Conversion Table
- Opioids: Generic and Brand Names Available in Canada
Appendix B-8.1 Oral Opioid Analgesic Conversion Table
- The table is based on oral dosing for chronic non-cancer pain.
- The figures are based on the Compendium of Pharmaceutical & Specialties (Canadian Pharmacists Association 2008) and a systematic review by Pereira (2001). Wide ranges have been reported in the literature.
- These equivalences refer to analgesic strength of oral opioids, and not psychoactive effects or effectiveness in relieving withdrawal symptoms.
- Equivalence to oral morphine 30 mg:
- Equivalence between oral morphine and transdermal fentanyl:
Table B Appendix 8.1 Oral Opioid Analgesic Conversion Table
| Equivalence to oral morphine 30 mg: | To convert to oral morphine equivalent, multiply by: | To convert from oralmorphine, multiply by: | |
| Morphine | 30 mg | 1 | 1 |
| Codeine | 200 mg | 0.15 | 6.67 |
| Oxycodone | 20 mg | 1.5 | 0.667 |
| Hydromorphone | 6 mg | 5 | 0.2 |
| Meperidine | 300 mg | 0.1 | 10 |
| Methadone and tramadol | Morphine dose equivalence not reliably established. | ||
| Transdermal fentanyl* | 60–134 mg morphine = 25mcg/h |
| 135–179 mg = 37 mcg/h | |
| 180–224 mg = 50 mcg/h | |
| 225–269 mg = 62 mcg/h | |
| 270–314 mg = 75 mcg/h | |
| 315–359 mg = 87 mcg/h | |
| 360–404 mg = 100 mcg/h |
* Formulations include 12, 25, 50, 75 and 100 ucg/hour patches, but the 12 ucg/hour patch is generally used for dose adjustment rather than initiation of fentanyl treatment.
Appendix B-8.2 Opioids: Generic and Brand Names Available in Canada
Strong Opioids
| Drug (generic name) | Brand names |
| Fentanyl (transdermal) | Duragesic® |
| Hydromorphone HCL | Dilaudid®, Hydromorph Contin®, Hydromorphone HCL, Hydromorphone HP® (10, 20, 50, Forte), Jurnista®, PMS-Hydromorphone® |
| Methadone HCL | Metadol® |
| Morphine sulfate | Statex®, Kadian®, M-Eslon®, M.O.S.-Sulfate®, Morphine HP, Morphine sulphate, MS Contin®, MS-IR®, PMS-Morphine®, Morphine Sulfate SR®, ratio-Morphine SR® |
| Oxycodone HCL | OxyContin®, Oxy-IR®, Supeudol® |
| Oxycodone HCL with acetaminophen | Endocet®, Percocet®, Percocet-Demi®, ratio-Oxycocet®, PMS- Oxycodone- Acetaminophen® |
| Oxycodone HCL/ ASA | Endodan®, Percodan®, Percodan-Demi®, ratio-Oxycodan® |
Weak Opioids
| Drug (generic name) | Brand names |
| Codeine monohydrate/ sulphate trihydrate | Codeine, Codeine Contin® |
| Codeine phosphate / acetaminophen / caffeine | Tylenol® (No. 1, 2, 3); Atasol® (No. 8, 15, 30); Lenoltec® |
| Codeine phosphate / acetaminophen without caffeine | Empracet® |
| Propoxyphene Napsylate | Darvon-N® |
| Pentazocine HCL | *Talwin® |
| Pethidine HCL (meperidine) | Demerol® |
| **Tramadol | Ralivia™, Zytram XL®, Tridural™ |
| **Tramadol/ Acetaminophen | Tramacet® |
Cannabinoids
| Drug (generic name) | Brand names |
| Nabilone | Cesamet® |
| Dronabinol | Marinol® |
| ***Sativex® |
* Opioid agonist/antagonist
** Tramadol is a weak opioid and serotonin/norepinephrine reuptake inhibitor
*** Orobuccal spray containing extracts of natural cannabis
Note: Reference throughout this document to specific pharmaceutical products as examples does not imply endorsement of any of these products.

[SITE MAP]
[BACK]
[TOP]